Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: Examining the early impact of Scotland's Hepatitis C Action Plan

Journal of Viral Hepatitis

Volumn 21, Issue 5, 2014, Pages 366-376

  McDonald, S A ^a,b   Hutchinson, S J ^a,b   Innes, H A ^a,b   Allen, S ^c   Bramley, P ^d   Bhattacharyya, D ^e   Carman, W ^f   Dillon, J F ^g   Fox, R ^h   Fraser, A ⁱ   Goldberg, D J ^a   Kennedy, N ^j   Mills, P R ^h   Morris, J ^k   Stanley, A J ^l   Wilks, D ^m   Hayes, P C ⁿ  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c CROSSHOUSE HOSPITAL   (United Kingdom)

^d Stirling Royal Infirmary   (United Kingdom)

^e Kirkcaldy Hospital   (United Kingdom)

^f West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

^h GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

ⁱ ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^j MONKLANDS HOSPITAL   (United Kingdom)

^k SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^l GLASGOW ROYAL INFIRMARY   (United Kingdom)

^m WESTERN GENERAL HOSPITAL   (United Kingdom)

ⁿ ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

more..

Author keywords

antiviral therapy; hepatitis C virus; public health intervention

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; FEMALE; GENOTYPE; HELP SEEKING BEHAVIOR; HEPATITIS C; HIGH RISK POPULATION; HOSPITAL; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT ATTITUDE; PRIORITY JOURNAL; PRISON; PROPHYLAXIS; PUBLIC HEALTH; UNITED KINGDOM; ADOLESCENT; AGED; AMBULATORY CARE; HEPATITIS C, CHRONIC; MIDDLE AGED; SPECIALIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SCOTLAND; SPECIALIZATION; YOUNG ADULT;

EID: 84898454926     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12153     Document Type: Article

References (15)

1. Hutchinson SJ, Bird SM, Taylor A, Goldberg DJ,. Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: implications for prevention. Int J Drug Policy 2006; 17 (3): 211-221.
2. Foster GR, Goldin RD, Main J, Murray-Lyon I, Hargreaves S, Thomas HC,. Management of chronic hepatitis C: clinical audit of biopsy based management algorithm. BMJ 1997; 315 (7106): 453-458.
3. Lowry DJ, Ryan JD, Ullah N, Kelleher TB, Crowe J,. Hepatitis C management: the challenge of dropout associated with male sex and injection drug use. Eur J Gastroenterol Hepatol 2011; 23 (1): 32-40.
4. Nguyen OK, Dore GJ, Kaldor JM, Hellard ME,. ATAHC Protocol Steering Committee. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study. Int J Drug Policy 2007; 18 (5): 447-451.
5. Irving WL, Smith S, Cater R, et al,. Clinical pathways for patients with newly diagnosed hepatitis C-what actually happens. J Viral Hepat 2006; 13 (4): 264-271.
6. Tait JM, McIntyre PG, McLeod S, Nathwani D, Dillon JF,. The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre. J Viral Hepat 2010; 17 (10): 698-704.
7. Gidding HF, Law MG, Amin J, et al,. Hepatitis C treatment outcomes in Australian clinics. Med J Aust 2012; 196 (10): 633-637.
8. Scottish Government Health Department. Hepatitis C Action Plan for Scotland: Phase II: May 2008-March 2011. Scottish Government: Edinburgh, 2008.
9. Health Protection Agency. Hepatitis C in UK 2012. London: Health Protection Agency Centre for Infections, 2012.
10. Shaw L, Taylor A, Roy K, et al,. Establishment of a database of diagnosed HCV-infected persons in Scotland. Commun Dis Public Health 2003; 6 (4): 305-310.
11. Health Protection Scotland (HPS). Surveillance of known hepatitis C antibody positive cases in Scotland: results to 31 December 2009. HPS Weekly Report 2010; 44(2010/18): 175-178.
12. Hope V, Parry JV, Marongui A, Ncube F,. Hepatitis C infection among recent initiates to injecting in England 2000-2008: is a national hepatitis C action plan making a difference? J Viral Hepat 2012; 19 (1): 55-64.
13. Lettmeier B, Muhlberger N, Schwarzer R, et al,. Market uptake of new antiviral drugs for the treatment of hepatitis C. J Hepatol 2008; 49 (4): 528-536.
14. Bruggmann P,. Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers. J Viral Hepatitis 2012; 19: 829-835.
15. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D,. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27 (4): 299-309.